Team, Inc. TISI 深 滬
等待開盤 01-08 09:30:00 美东时间
14.12
+0.070
+0.50%
華盛通- 最 高14.45
- 今 開13.99
- 成交量 1600股
- 最 低 13.99
- 昨 收 14.05
- 總市值 6352.45万
- 52周最高 24.25
- 市盈率 靜 --
- 換手率 0.04%
- 52周最低 12.115
- 委 比 0.00%
- 總股本 449.89万
- 歷史最高 480.90
- 量 比 0.04
- 振 幅 3.27%
- 歷史最低 3.5301
- 每 手 1
- 風險率 2.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多夜读 | 黄仁勋CES“炸场秀”后的精彩问答来了！谈及关键临界点、护城河、马斯克以及亿万富翁税等
黄仁勋CES“炸场秀”后的精彩问答出炉！谈及关键临界点、护城河、马斯克以及亿万富翁税等>>
01-07 23:59
Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108
Palisade Bio, Inc. has received a strategic equity investment of up to $500,000 from the Crohn’s & Colitis Foundation, supporting the development of PALI-2108, a targeted PDE4 inhibitor for ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD). PALI-2108, designed for local delivery to the terminal ileum and colon, aims to address significant unmet needs by targeting inflammation and fibrosis with minimal systemic effects. The investme...
01-07 13:15
Abacus Global Management Launches Asset-Based Finance Strategy
Abacus Global Management launches an asset-based finance (ABF) strategy led by Monty Cook and Elena Plesco, former executives from Varde Partners and KKR. The strategy combines institutional origination expertise with Abacus's proprietary insurance analytics to target the $20 trillion asset-based finance market. Focused on stable cash flows and low volatility, the ABF strategy will invest in asset-backed opportunities, including consumer credit, ...
01-06 21:05
Galecto Announces Key Additions to Leadership Team
Galecto, a biotech company developing treatments for blood cancers, has appointed Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as Chief Medical Officer. Both executives bring extensive experience in hematology/oncology drug development. The company is advancing DMR-001, a mutCALR-targeting monoclonal antibody, with an IND submission expected in mid-2026. Galecto's cash balance, including $285 million raised in November 2025...
01-06 13:00
Fortinet to Announce Fourth Quarter and Full Year 2025 Financial Results
Fortinet, a global leader in cybersecurity, announced it will host a conference call on February 5, 2026, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its fourth quarter and full year 2025 financial results. The call will be available live on Fortinet's investor relations website, with materials and a replay accessible afterward. Fortinet, known for its extensive cybersecurity portfolio, serves over half a million customers and c...
01-05 14:00
Treasure Global Regains Compliance with Nasdaq Bid Price Requirement
KUALA LUMPUR,马来西亚，2026年1月5日（GLOBE NEWSWIRE）——Treasure Global Inc.（纳斯达克股票代码：TGL）今天宣布，该公司于2025年12月23日收到纳斯达克的通知，确认其已恢复符合纳斯达克最低出价要求。纳斯达克已确认原定于2026年1月27日举行的听证会取消。Treasure Global的普通股将继续在纳斯达克市场交易。公司首席执行官表示，恢复合规后，公司将专注于执行战略计划并创造长期股东价值。Treasure Global是一家以马来西亚为基础的技术公司，旗下ZCITY超级应用程序整合了电子支付和客户忠诚度奖励，截至2025年6月已吸引超过270万名注册用户。
01-05 13:35
Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer
Hyperion DeFi announced the appointment of Hyunsu Jung as CEO and Robert Rubenstein as General Counsel, alongside David Knox as CFO, to advance its strategic priorities. Jung, previously CIO, brings expertise in digital asset strategies, while Rubenstein offers decades of legal experience. The Company focuses on building a leading DeFi platform, Hyperliquid, with its native HYPE token, and developing the Optejet device for ophthalmic use.
01-05 13:00
Rogers Launches The Great Canadian Jersey
Rogers launches 'The Great Canadian Jersey' campaign, inviting Canadians to donate old hockey jerseys to create unique, patchwork versions representing the nation's hockey heritage. These will be designed by Cameron Lizotte and worn by pro players like Connor McDavid and Marie-Philip Poulin. Donations are accepted at Rogers stores until January 15, with a chance to win a VIP hockey trip.
01-05 13:00
CNH announces appointments to Global Leadership Team
CNH announced the appointments of Carlo Materazzo as Chief Manufacturing Officer and Britton Worthen as Chief Legal & Compliance Officer, effective January 1, 2026. Carlo, with over 20 years of manufacturing experience, oversees global agricultural operations in five regions and 15 countries. Britton brings extensive legal and governance expertise, advising on key legal issues and serving as Board Secretary. CEO Gerrit Marx expressed confidence i...
01-02 11:30
AIM ImmunoTech Announces Stock Dividend
AIM ImmunoTech Inc. (NYSE American: AIM) announced a stock dividend of one share of common stock for every 1,000 shares outstanding and one share for every outstanding option or warrant. The dividend will be issued to shareholders and Alternate Securities holders of record as of January 9, 2026, and distributed to DTCC on January 13, 2026. Fractional shares will be rounded down, with remaining fractions paid in cash based on a $1.305 per-share pr...
2025-12-30 22:10
